Skip to main content

Table 5 Provider knowledge of first-line treatment and dosing regimens, by sector¹

From: Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries

  Benin DRC Madagascar Nigeria Uganda Zambia
  Public/Not-for-Profit Private Public/Not- for-Profit Private Public/Not- for-Profit Private Public/Not- for-Profit Private Public/Not- for-Profit Private Public/Not- for-Profit Private
  N=218 N=735 N=135 N=1, 242 N=575 N=2, 016 N=258 N=1, 839 N=563 N=699 N=178 N=283
Correctly state the recommended first-line treatment for uncomplicated malaria 73.0 a 17.7 b 76.4 a 42.4 b 71.7 a 12.4 b 43.7 a 25.5 b 92.8 a 59.8 b 92.7 a 59.3 b
Correctly state the dosing regimen of the first-line treatment for an adult 70.7 a 8.4 b 70.4 a 28.5 b 42.4 a 5.1 a --2 -- 86.6 a 53.2 a 92.7 a 48.2 b
Correctly state the dosing regimen of the first-line treatment for a two year old 70.2 a 7.8 b 69.6 a 28.4 b 68.8 a 8.5 b -- -- 89.5 a 49.3 b 92.7 a 47.3 b
  1. ¹ Statistical comparisons conducted across outlet types, within countries. Statistical difference is labelled with a superscript, a or b. Proportions with different letters in their superscripts differ significantly from one another within countries (p < 0.01 for all tests).
  2. 2 Information on Nigeria's dosing regimen for their first-line alternative ACT, ASAQ, was not collected.